Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice, Treatment Improvement Protocol (TIP) Series, No. 49, U.S. Department of Health and Human Services, 2009.
Drug and Alcohol Dependence: “Alcohol and Opioid Dependence Medications: Prescription Trends, Overall and by Physician Specialty.”
Stephen Richard Holt, MD, MS, FACP, associate professor, Yale School of Medicine; associate program director, ambulatory education, Yale Primary Care Residency Program; co-director, Addiction Recovery Clinic, Yale New Haven Hospital Saint Raphael Campus, New Haven, CT.
Gerard J. Schmidt, MA, MAC, LPC, CAC, president, NAADAC, the Association for Addiction Professionals; chief operations officer, Valley HealthCare System, Morgantown, WV.
National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition), U.S. Department of Health and Human Services, 2018.
Substance Abuse and Mental Health Services Administration/National Institute on Alcohol Abuse and Alcoholism. Medication for the Treatment of Alcohol Use Disorder: A Brief Guide, U.S. Department of Health and Human Services, 2015.
New England Journal of Medicine: “Naltrexone for the Management of Alcohol Dependence.”
The Brain From Top to Bottom, McGill: “Anxiety Neurotransmitters.”
Purves, D. Neuroscience, 2nd ed., Sinauer Associates, 2001.
Substance Abuse: Research and Treatment: “Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence.”
UpToDate: “Pharmacotherapy for alcohol use disorder.”